Engineered single-domain antibodies with high protease resistance and thermal stability
about
An update on antibody-based immunotherapies for Clostridium difficile infectionStability engineering of the human antibody repertoireEvaluation of disulfide bond position to enhance the thermal stability of a highly stable single domain antibodyVHH antibodies: emerging reagents for the analysis of environmental chemicalsThe role of intra-domain disulfide bonds in heat-induced irreversible denaturation of camelid single domain VHH antibodiesEffects of localized interactions and surface properties on stability of protein-based therapeutics.Efficient generation of single domain antibodies with high affinities and enhanced thermal stabilities.Disulfide linkage engineering for improving biophysical properties of human VH domains.Engineered antibody variable and constant domains as therapeutic candidates.Protease-resistant single-domain antibodies inhibit Campylobacter jejuni motility.Development and evaluation of single domain antibodies for vaccinia and the L1 antigenSelection of nanobodies that block the enzymatic and cytotoxic activities of the binary Clostridium difficile toxin CDTTargeting surface-layer proteins with single-domain antibodies: a potential therapeutic approach against Clostridium difficile-associated diseaseEnhanced production of a single domain antibody with an engineered stabilizing extra disulfide bondImportance of Hypervariable Region 2 for Stability and Affinity of a Shark Single-Domain Antibody Specific for Ebola Virus NucleoproteinAntibody light chain variable domains and their biophysically improved versions for human immunotherapy.Immunoglobulin domains in Escherichia coli and other enterobacteria: from pathogenesis to applications in antibody technologies.Nanobody-based cancer therapy of solid tumors.Review cyclic peptides on a merry-go-round; towards drug design.Exploiting sequence and stability information for directing nanobody stability engineering.Emerging monoclonal antibodies against Clostridium difficile infection.Blocking of Histamine Release and IgE Binding to FcεRI on Human Basophils by Antibodies Produced in Camels.Enhancing Stability of Camelid and Shark Single Domain Antibodies: An Overview.Characterization of highly concentrated antibody solution - A toolbox for the description of protein long-term solution stabilityImproving the biophysical properties of anti-ricin single-domain antibodies.Neutralization of Clostridium difficile Toxin B Mediated by Engineered Lactobacilli That Produce Single-Domain Antibodies.Selection, characterization, and thermal stabilization of llama single domain antibodies towards Ebola virus glycoprotein.Application of Assisted Design of Antibody and Protein Therapeutics (ADAPT) improves efficacy of a Clostridium difficile toxin A single-domain antibody.Highly efficient and easy protease-mediated protein purification.Single-Domain Antibodies and the Promise of Modular Targeting in Cancer Imaging and Treatment.Preclinical Development of a Novel, Orally-Administered Anti-Tumour Necrosis Factor Domain Antibody for the Treatment of Inflammatory Bowel Disease.Enhanced stabilization of a stable single domain antibody for SEB toxin by random mutagenesis and stringent selection.
P2860
Q26740788-7EDBC22D-C8FA-4722-94FA-D61F400D00A1Q26859495-B679B612-CFD2-4921-AACA-0B1DDF3491D8Q28384605-9B0FAB55-8FE8-45C6-9441-0693E4AE3C42Q28386514-EB4A1307-2AE5-40B2-99FA-6850C9A90336Q28833254-637B7E17-F1F9-4D30-A121-D9E2E9BB91B4Q30395368-33F64D23-D5E0-4C66-B9A0-CB5F6329B42BQ33919030-F083F613-5989-4737-BE41-46FCC75027F2Q34401520-1DB663D5-2422-4B0F-8384-17B474AA29F4Q35044156-F6026BEC-9056-431B-9C14-451EF19C75BDQ35151390-A69E3235-8129-4C8B-AE81-193829EA300AQ35248202-4B3B8CD8-3841-4A0A-873E-4C177DC913CCQ35544342-462A3FDA-C5F7-4DF5-8AA3-22E37E311764Q35621057-B082F5FB-2DC9-406B-A321-E919AC73E155Q35800979-720200F6-5454-4AA6-9451-02CCE23D2A08Q36096006-D7AEF595-9908-491E-9DDB-290DCE0F66D5Q37593692-69DCFB89-C7DC-4E2D-AC1E-C3BD6098827AQ38020872-EA1CC96B-9217-4781-A57E-45BDF8FCAD87Q38322471-A2E374F1-ABA2-479B-9836-21E822628208Q38476515-2BF9A25E-DDBD-40D0-A41C-591553D5272AQ38713206-CC687B0F-39E5-4443-8551-76F3CA370595Q39168914-EEC69E2A-3894-4D8A-821C-1CFF2CD88F12Q40580798-D42EF56B-B169-4343-83E7-C87BC2F6D15AQ41108385-1710BA32-C132-40DF-874F-290C1AD6A6AAQ42111378-3593ABD5-73A7-4A9D-A491-C26603C09F0EQ42210192-C817B3D2-A9F2-4C66-A61A-471F5B810D84Q42697422-E83E2F88-B607-4F72-9A23-FBAF43901E94Q47256875-169476CF-6EBD-4104-AB23-177047617A84Q49357853-5357AA7E-45BF-4434-9FEA-8CF0024D4C98Q50237169-A85076DD-3ED2-490A-92B8-0D9425902E21Q52362264-7A48F2FB-6641-4E20-A050-0A3D69D09AA8Q52643911-E9BF0072-0634-4DFB-9BF9-887A70E0140EQ53627592-0AA016A5-D836-4ABD-9EAA-7052290C4FD1
P2860
Engineered single-domain antibodies with high protease resistance and thermal stability
description
2011 nî lūn-bûn
@nan
2011 թուականին հրատարակուած գիտական յօդուած
@hyw
2011 թվականին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Engineered single-domain antibodies with high protease resistance and thermal stability
@ast
Engineered single-domain antibodies with high protease resistance and thermal stability
@en
Engineered single-domain antibodies with high protease resistance and thermal stability
@nl
type
label
Engineered single-domain antibodies with high protease resistance and thermal stability
@ast
Engineered single-domain antibodies with high protease resistance and thermal stability
@en
Engineered single-domain antibodies with high protease resistance and thermal stability
@nl
prefLabel
Engineered single-domain antibodies with high protease resistance and thermal stability
@ast
Engineered single-domain antibodies with high protease resistance and thermal stability
@en
Engineered single-domain antibodies with high protease resistance and thermal stability
@nl
P2093
P2860
P3181
P1433
P1476
Engineered single-domain antibodies with high protease resistance and thermal stability
@en
P2093
Greg Hussack
Jamshid Tanha
Roger Mackenzie
Tomoko Hirama
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0028218
P407
P577
2011-01-01T00:00:00Z